Mice Model Market Worth 1,370.5 Million USD By 2023
The global Mice
model (Models, services and care products)
market is expected to grow at a CAGR of 7.2% during the projected period to
reach USD 1,370.54 million by 2023 from USD 968.36 million in 2018. The growth
of this market is mainly attributed to the continuing modification in mice
model for cancers, immune diseases, and rare diseases; increasing devouring of
personalized medicine propelling the demand for humanized mice model; rising
grants and investments for biological research; rising pharmaceutical R&D
activities; and increasing focus of International Mouse Phenotyping Consortium
(IMPC) and International Knockout Mouse Consortium (IKMC) on the development of
embryonic stem cells as well as knockout and mutant mice.
Browse in-depth Report on:
https://www.meticulousresearch.com/product/mice-model-market/
The evolution of alternative techniques to
animal testing, improvement in zebrafish model development, and growing need
for improved mice models are the major challenges in the global mice model
market. In addition, evolution of CRISPR-Cas9 gene editing technology in the
field of biomedical research, increasing demand for humanized mice model, and
rising monoclonal antibody production provides significant opportunities for
the various stakeholders in the global mice model market. However, factors such
as increasing use of rat models, increased advantages from cryopreservation,
and government regulations and laws for ethical use of animals in research
hampers the growth of mice model market to some extent.
Market dynamics:
The continuous modification in mice model
allows researchers to find out the appropriate solution for complex biology
during the treatment of various chronic diseases. The mouse models are playing
important role in the development of immune therapies. For instance, the recent
research led by University of California developed a new class of drugs known
as immune checkpoint inhibitors. These drugs have been used for the treatment
of a growing number of patients with cancer, including some who had run out of
treatment options.
For detail study insights , download key sample:
https://www.meticulousresearch.com/download-sample-report/cp_id=4151
Cancer remains to be the second leading cause
of death in the U.S., it was estimated that in 2017, 30% of all new cancer
cases among women were breast cancer. In 2018, the federal budget prioritizes
Medical Research and Cancer Prevention, which includes a $3 billion increase
for medical research at the National Institutes of Health (NIH) a $275 million
increase for the National Cancer Institute (NCI); a $10 million increase for
cancer prevention programs at the Centers for Disease Control and Prevention
(CDC).
Trends
The rapidly growing ageing population and
advances in cancer therapy have sparked tremendous interest in the improvement
of mice models. For many years, cancer biologists have taken two distinct approaches
to modeling cancer. One is to grow immortalized human cancer cells, known as
cancer cell lines in a lab dish, but they don’t really reproduce the complex in vivo environment of a tumor.
Contact Info:
Meticulous Market Research Pvt. Ltd.
Email: sales@meticulousresearch.com
Contact Sales-
Comments
Post a Comment